Healthcare provider profile · identity verified

Gennady Nosovitsky, PA-C

Physician Assistant · CATHEDRAL CITY, CA · NPI 1780007708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	487	50
Tivicay	Dolutegravir Sodium	479	48
Pifeltro	Doravirine	395	41
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	298	34
Valacyclovir	Valacyclovir Hcl	244	30
Descovy	Emtricitabine/Tenofov Alafenam	234	28
Gabapentin	Gabapentin	216	31
Xyosted	Testosterone Enanthate	212	30
Pantoprazole Sodium	Pantoprazole Sodium	202	25
Bupropion Xl	Bupropion Hcl	199	20
Omeprazole	Omeprazole	196	24
Tamsulosin Hcl	Tamsulosin Hcl	186	25
Maraviroc	Maraviroc	171	18
Metformin Hcl Er	Metformin Hcl	162	18
Dovato	Dolutegravir Sodium/Lamivudine	145	16
Fluconazole	Fluconazole	141	16
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	137	24
Vascepa	Icosapent Ethyl	134	18
Montelukast Sodium	Montelukast Sodium	127	16
Dutasteride	Dutasteride	120	15
Mounjaro	Tirzepatide	118	15
Rukobia	Fostemsavir Tromethamine	113	11
Nebivolol Hcl	Nebivolol Hcl	112	14
Repatha Sureclick	Evolocumab	111	18
Atorvastatin Calcium	Atorvastatin Calcium	110	17
Levothyroxine Sodium	Levothyroxine Sodium	103	15
Tadalafil	Tadalafil	103	14
Losartan Potassium	Losartan Potassium	98	13
Silodosin	Silodosin	97	13
Carvedilol Er	Carvedilol Phosphate	88	suppressed
Duloxetine Hcl	Duloxetine Hcl	87	suppressed
Testosterone	Testosterone	87	18
Clopidogrel	Clopidogrel Bisulfate	86	suppressed
Praluent Pen	Alirocumab	86	11
Eplerenone	Eplerenone	77	suppressed
Eliquis	Apixaban	67	suppressed
Lisinopril	Lisinopril	66	suppressed
Trazodone Hcl	Trazodone Hcl	66	suppressed
Finasteride	Finasteride	65	suppressed
Xarelto	Rivaroxaban	60	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	58	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	55	suppressed
Synthroid	Levothyroxine Sodium	54	suppressed
Propranolol Hcl Er	Propranolol Hcl	53	suppressed
Amlodipine Besylate	Amlodipine Besylate	52	suppressed
Myrbetriq	Mirabegron	51	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	50	20
Mometasone Furoate	Mometasone Furoate	46	suppressed
Loperamide	Loperamide Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	44	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	suppressed
Dexlansoprazole Dr	Dexlansoprazole	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Testosterone Cypionate	Testosterone Cypionate	41	suppressed
Flunisolide	Flunisolide	40	15
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Isentress Hd	Raltegravir Potassium	38	suppressed
Nevirapine Er	Nevirapine	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Juluca	Dolutegravir/Rilpivirine	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Famotidine	Famotidine	34	suppressed
Minoxidil	Minoxidil	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Colchicine	Colchicine	31	suppressed
Allopurinol	Allopurinol	28	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Carvedilol	Carvedilol	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Cabenuva	Cabotegravir/Rilpivirine	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	26	suppressed
Prazosin Hcl	Prazosin Hcl	26	suppressed
Repatha Pushtronex	Evolocumab	26	11
Selzentry	Maraviroc	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	24	suppressed
Baclofen	Baclofen	24	suppressed
Furosemide	Furosemide	24	suppressed
Imiquimod	Imiquimod	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Anastrozole	Anastrozole	23	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Edurant	Rilpivirine Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Metoprolol Succinate	Metoprolol Succinate	20	suppressed
Ozempic	Semaglutide	19	suppressed
Levetiracetam Er	Levetiracetam	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	18	suppressed
Azithromycin	Azithromycin	17	13
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Dexilant	Dexlansoprazole	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Ramelteon	Ramelteon	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Xiidra	Lifitegrast	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	15	suppressed
Icosapent Ethyl	Icosapent Ethyl	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	14	suppressed
Rexulti	Brexpiprazole	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lamictal Xr	Lamotrigine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Valganciclovir Hcl	Valganciclovir Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Abacavir-Lamivudine	Abacavir Sulfate/Lamivudine	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Cyclobenzaprine Hcl Er	Cyclobenzaprine Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oracea	Doxycycline Monohydrate	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Soolantra	Ivermectin	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error